Recent advances in novel miRNA mediated approaches for targeting breast cancer
Breast cancer (BC) is considered one of the most frequent cancers among woman worldwide. While conventional therapy has been successful in treating many cases of breast cancer, drug resistance, heterogenicity, tumour features and recurrence, invasion, metastasis and the presence of breast cancer stem cells can hinder the effect of treatments, and can reduce the quality of life of patients. MicroRNAs (miRNAs) are short non-coding RNA molecules that play a crucial role in the development and progression of breast cancer. Several studies have reported that aberrant expression of specific miRNAs is associated with the pathogenesis of breast cancer. However, miRNAs are emerging as potential biomarkers and therapeutic targets for breast cancer. Understanding their role in breast cancer biology could help develop more effective treatments for this disease. The present study discusses the biogenesis and function of miRNAs, as well as miRNA therapy approaches for targeting and treating breast cancer cells.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
Journal of drug targeting - 31(2023), 8 vom: 22. Sept., Seite 777-793 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ahmadi, Seyedeh Melika [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomarkers |
|---|
| Anmerkungen: |
Date Revised 01.09.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1080/1061186X.2023.2240979 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359805736 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359805736 | ||
| 003 | DE-627 | ||
| 005 | 20231226081648.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/1061186X.2023.2240979 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1199.xml |
| 035 | |a (DE-627)NLM359805736 | ||
| 035 | |a (NLM)37480323 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ahmadi, Seyedeh Melika |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Recent advances in novel miRNA mediated approaches for targeting breast cancer |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Breast cancer (BC) is considered one of the most frequent cancers among woman worldwide. While conventional therapy has been successful in treating many cases of breast cancer, drug resistance, heterogenicity, tumour features and recurrence, invasion, metastasis and the presence of breast cancer stem cells can hinder the effect of treatments, and can reduce the quality of life of patients. MicroRNAs (miRNAs) are short non-coding RNA molecules that play a crucial role in the development and progression of breast cancer. Several studies have reported that aberrant expression of specific miRNAs is associated with the pathogenesis of breast cancer. However, miRNAs are emerging as potential biomarkers and therapeutic targets for breast cancer. Understanding their role in breast cancer biology could help develop more effective treatments for this disease. The present study discusses the biogenesis and function of miRNAs, as well as miRNA therapy approaches for targeting and treating breast cancer cells | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a biomarkers | |
| 650 | 4 | |a breast cancer | |
| 650 | 4 | |a cancer | |
| 650 | 4 | |a drug delivery | |
| 650 | 4 | |a miRNA | |
| 650 | 4 | |a polymer | |
| 700 | 1 | |a Amirkhanloo, Shervin |e verfasserin |4 aut | |
| 700 | 1 | |a Yazdian-Robati, Rezvan |e verfasserin |4 aut | |
| 700 | 1 | |a Ebrahimi, Hossein |e verfasserin |4 aut | |
| 700 | 1 | |a Pirhayati, Faezeh Hosseini |e verfasserin |4 aut | |
| 700 | 1 | |a Almalki, Waleed H |e verfasserin |4 aut | |
| 700 | 1 | |a Ebrahimnejad, Pedram |e verfasserin |4 aut | |
| 700 | 1 | |a Kesharwani, Prashant |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of drug targeting |d 1996 |g 31(2023), 8 vom: 22. Sept., Seite 777-793 |w (DE-627)NLM074733958 |x 1029-2330 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2023 |g number:8 |g day:22 |g month:09 |g pages:777-793 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/1061186X.2023.2240979 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2023 |e 8 |b 22 |c 09 |h 777-793 | ||